NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Antioxidant peptides from swim bladders as monkfish by-products could improve the treatment of nonalcoholic fatty liver disease (NAFLD) by controlling oxidative stress and lipid accumulation via regulating AMP-activated protein kinase (AMPK) and nuclear factor erythroid 2-related factor 2 (Nrf2) signal pathways [47,48].